Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ovarian stimulation trigger protocol comparison in IVF for women with diminished ovarian reserve
IRCT20130808014301N4Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2026
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, single-blind trial of human chorionic gonadotropin, follitropin alfa and triptorelin in female infertility and Diminished Ovarian Reserve (DOR) (3 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Total number of oocytes retrieved, Number of mature MII oocytes and 2 more. Started Mar 2026; status: completed.
02
Drugs
human chorionic gonadotropinfollitropin alfatriptorelin
03
Conditions
female infertilityDiminished Ovarian Reserve (DOR)
Beyond the preview
Go deeper on IRCT20130808014301N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130808014301N4.